Skip to content

Lantheus Holdings LNTH Definity — Revenue

Other product segments

Oncology
$240.92M
PYLARIFY
$240.92M-6.5%
Cardiology
$84.63M
Neuraceq
$35.44M
Neurology
$35.44M
Strategic Partnerships And Other
$16.34M+52.1%
Licenseand Royalty Revenues
$7.48M+28.0%
SPECT Business
$0

Similar metrics at other companies

Mobileye Global Inc. logo
MBLYDE — Revenue
$77M+4.1%
Bruker logo
BRKRDE — Revenue
$62.7M+2.6%
LQD
LQDAProduct — Revenue
$129.88M
PTC logo
PTCDE — Revenue
$92.2M+11.6%
Tempus AI, Inc. logo
TEMDiagnostics — Revenue
$261.1M+34.7%
PTC Therapeutics logo
PTCTProduct — Revenue
$225.57M+47.0%

Other financials

Income statement

See full
Revenue$377.3M+1.2%
Gross profit$230.9M-2.9%
Operating income$81.3M-20.3%
Net income$118.4M+62.3%
EPS (diluted)$1.80+76.5%

Balance sheet

See full
Cash & equivalents$500.3M-46.8%
Total debt$627.9M+1.8%
Total equity$1.2B+4.1%
Total assets$2.3B+14.2%

Cash flow

See full
Operating cash flow$125.1M+16.3%
CapEx$3.2M-63.0%
Free cash flow$121.9M+23.3%

Valuation

See full
Market cap$6.76B-26.3%
Enterprise value$6.89B-20.5%
P/E24.2×-10.2×
P/S4.4×-1.6×

Profitability

See full
Gross margin60.5%-3.6pp
Operating margin18.8%-10.7pp
Net margin18%+0.7pp
FCF margin24.4%-6.4pp

Returns & leverage

See full
Return on equity23.5%-1.7pp
Debt / equity0.5×0.0×
Current ratio2.8×-2.9×

Where this comes from

Reported directly by Lantheus Holdings in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Lantheus Holdings’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lantheus Holdings's definity — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lantheus Holdings's definity — revenue?
Lantheus Holdings (LNTH) reported definity — revenue of $84.63M in Q1 2026.
How has Lantheus Holdings's definity — revenue changed year-over-year?
Lantheus Holdings's definity — revenue increased by 6.8% year-over-year, from $79.21M to $84.63M.
What is the long-term trend for Lantheus Holdings's definity — revenue?
Over 4 years (2021 to 2025), Lantheus Holdings's definity — revenue has grown at a 9.1% compound annual growth rate (CAGR), from $232.76M to $330.25M.
What does definity — revenue mean?
This metric represents the total gross revenue generated from the sale of a specific diagnostic product line, net of any assessed taxes. It serves as a primary indicator of market demand and commercial adoption for the company's core diagnostic offerings. Tracking this figure allows investors to assess the growth trajectory and revenue contribution of the product segment relative to the company's total portfolio.